Tamuzimod delivers promising long-term data in ulcerative colitis Presented ByProf. Silvio Danese, Vito-Salute San Raffaele University, Italy TrialPhase 2 ConferenceUEGW 2024 TypeNews article 16 October 2024 11:15
CULTIVATE: Good signal for etrasimod in Crohn’s disease Presented ByProf. Geert D’Haens, Amsterdam University Medical Center, the Netherlands TrialPhase 2, CULTIVATE ConferenceUEGW 2024 TypeNews article 15 October 2024 10:22
Upadacitinib associated with normalisation of HRQoL in UC Presented ByProf. Joana Torres, Hospital Beatriz Ângelo, Portugal TrialU-ACHIEVE; U-ACCOMPLISH ConferenceUEGW 2024 TypeNews article 17 October 2024 16:09
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA Presented ByDr Serena Stigliano, University of Rome, Italy ConferenceUEGW 2024 TypeNews article 17 October 2024 16:08
New insights into perianal fistulising CD pathogenesis may lead to new therapeutics Presented ByDr Siyan Cao, Washington University in St Louis, USA ConferenceUEGW 2024 TypeNews article 17 October 2024 16:06
TL1A inhibitor tulisokibart shows potential in ulcerative colitis Presented ByDr Christopher Ma , University of Calgary, Canada TrialPhase 2, ARTEMIS-UC ConferenceUEGW 2024 TypeNews article 17 October 2024 10:11
An accelerated treatment approach may save lives in pancreatic walled-off necrosis Presented ByDr Gitte Olsen, Copenhagen University Hospital, Denmark TrialACCELERATE ConferenceUEGW 2024 TypeNews article 17 October 2024 10:09
Encouraging results for L-carnitine in non-alcoholic fatty liver disease Presented ByDr Pezhman Alavinejad, Ahvaz Jundishapur University of Medical Sciences, Iran ConferenceUEGW 2024 TypeNews article 17 October 2024 10:07
LOVE-CD: Vedolizumab yields better outcomes in early than in late CD Presented ByProf. Geert D’Haens, Amsterdam University Medical Center, the Netherlands TrialLOVE-CD ConferenceUEGW 2024 TypeNews article 17 October 2024 10:06
Exploring zibotentan plus dapagliflozin for cirrhosis Presented ByDr Phil Ambery TrialPhase 2, ZENITH-CKD ConferenceUEWG 2024 TypeNews article 17 October 2024 10:03
Tamuzimod delivers promising long-term data in ulcerative colitis Presented ByProf. Silvio Danese, Vito-Salute San Raffaele University, Italy TrialPhase 2 ConferenceUEGW 2024 TypeNews article 16 October 2024 11:15
Cendakimab meets primary endpoints in eosinophilic oesophagitis Presented ByDr Alain Schoepfer, University of Lausanne, Switzerland TrialPhase 3 ConferenceUEGW 2024 TypeNews article 16 October 2024 11:13
Tradipitant improves symptoms of motion sickness Presented ByDr Vasilios Polymeropoulos ConferenceUEGW 2024 TypeNews article 16 October 2024 11:10
How useful is colonoscopy for constipation in young women? Presented ByDr Amani Beshara, Hillel Yaffe Medical Center, Israel ConferenceUEGW 2024 TypeNews article 16 October 2024 11:08
Guar gum alleviates IBS-related constipation in randomised-controlled trial Presented ByDr Silvia Delgado-Aros, Nestle Health Sciences, Switzerland ConferenceUEGW 2024 TypeNews article 16 October 2024 11:06
CULTIVATE: Good signal for etrasimod in Crohn’s disease Presented ByProf. Geert D’Haens, Amsterdam University Medical Center, the Netherlands TrialPhase 2, CULTIVATE ConferenceUEGW 2024 TypeNews article 15 October 2024 10:22
Meaningful corticosteroid-sparing effect of mirikizumab in UC Presented ByProf. David Laharie, University of Bordeaux, France TrialPhase 3, LUCENT ConferenceUEGW 2024 TypeNews article 15 October 2024 10:22
Is FMT a viable option to treat primary C. difficile infections? Presented ByDr Frederik Juul, University of Oslo, Norway ConferenceUEGW 2024 TypeNews article 15 October 2024 10:22
Extending ustekinumab dosing interval does not influence drug survival in IBD Presented ByDr Monique Devillers, Erasmus MC, the Netherlands ConferenceUEGW 2024 TypeNews article 15 October 2024 10:15
TACITO: Does FMT improve ICI plus VEGFR TKI therapy in mRCC? Presented ByDr Gianluca Ianiro, Agostino Gemelli University Policlinic, Italy TrialPhase 2, TACITO ConferenceUEGW 2024 TypeNews article 15 October 2024 10:13